{
  "meta": {
    "title": "19_Corticosteroids_Sex_Hormones",
    "url": "https://brainandscalpel.vercel.app/19-corticosteroids-sex-hormones-594ab2e4.html",
    "scrapedAt": "2025-11-30T06:59:44.147Z"
  },
  "questions": [
    {
      "id": 73815,
      "choices": [
        {
          "id": 296508,
          "text": "Transdermal"
        },
        {
          "id": 296509,
          "text": "Intranasal"
        },
        {
          "id": 296510,
          "text": "Sublingual"
        },
        {
          "id": 296511,
          "text": "Inhalation through metered-dose nasal inhaler"
        }
      ],
      "text": "Desmopressin can be given by following routes except",
      "unique_key": "Q1076111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34931877,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Transdermal. Desmopressin is a synthetic analog of vasopressin (ADH) used to treat conditions like diabetes insipidus, nocturnal enuresis, and von Willebrand disease. It is not available in a transdermal formulation because it has poor absorption through the skin, making this route ineffective for systemic delivery. Instead, it is formulated for administration via oral (sublingual), intranasal, and injectable routes, which provide better bioavailability and rapid therapeutic effects. Incorrect Options: B. Intranasal: Desmopressin is available as an intranasal spray, which allows for rapid absorption through the nasal mucosa. This route is commonly used for central diabetes insipidus and nocturnal enuresis. C. Sublingual: A sublingual formulation of desmopressin (desmopressin lyophilisate) is available and provides effective systemic absorption, avoiding the first-pass metabolism. It is used particularly in conditions like nocturnal enuresis and hemophilia A. D. Inhalation through a metered-dose nasal inhaler: While less commonly used, desmopressin can be delivered through metered-dose nasal inhalers, functioning similarly to the intranasal spray. This method allows direct absorption into the bloodstream through the nasal mucosa, making it a viable option for some patients.",
      "correct_choice_id": 296508,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67373361700144933/67373361700144933.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67373361700144933/67373361700144933.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73816,
      "choices": [
        {
          "id": 296512,
          "text": "Terlipressin is better than desmopressin for esophageal variceal bleeding"
        },
        {
          "id": 296513,
          "text": "Desmopressin used for both pituitary and renal diabetes insipidus"
        },
        {
          "id": 296514,
          "text": "Desmopressin not much effective against Nephrogenic diabetes insipidus"
        },
        {
          "id": 296515,
          "text": "Amiloride used for lithium induced diabetes insipidus"
        }
      ],
      "text": "All are true except",
      "unique_key": "Q8474572",
      "question_audio": null,
      "question_video": null,
      "map_id": 34039853,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Desmopressin is used for both pituitary and renal diabetes insipidus (DI). Desmopressin is a synthetic vasopressin analog that primarily acts on V2 receptors in the kidney to promote water reabsorption. It is the treatment of choice for central (pituitary) diabetes insipidus, which occurs due to ADH deficiency. However, it is not effective in nephrogenic (renal) diabetes insipidus, where the kidneys are resistant to ADH. Since nephrogenic DI is due to an inability of the kidneys to respond to vasopressin, desmopressin has limited to no effect in this condition, making the statement incorrect. Incorrect Options: A. Terlipressin is better than desmopressin for esophageal variceal bleeding: This is true. Terlipressin is a vasopressin analog with V1 receptor activity, causing vasoconstriction and reducing portal pressure, which helps control esophageal variceal bleeding. Desmopressin mainly acts on V2 receptors, affecting water retention rather than vascular tone, making it ineffective for variceal bleeding. C. Desmopressin is not much effective against nephrogenic diabetes insipidus: This is true. In nephrogenic DI, the kidneys are unresponsive to ADH due to defects in V2 receptors or the aquaporin-2 water channels. Since desmopressin works by stimulating V2 receptors, it is largely ineffective in nephrogenic DI, which is instead managed with thiazide diuretics, NSAIDs, or amiloride (if lithium-induced). D. Amiloride is used for lithium-induced diabetes insipidus: This is true. Chronic lithium use can cause nephrogenic DI by impairing aquaporin-2 expression in the renal collecting ducts. Amiloride, a potassium-sparing diuretic, helps prevent lithium uptake in the kidneys, thereby reducing lithium-induced nephrogenic DI symptoms.",
      "correct_choice_id": 296513,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42834901700144945/42834901700144945.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42834901700144945/42834901700144945.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73817,
      "choices": [
        {
          "id": 296516,
          "text": "Ovarian cancer"
        },
        {
          "id": 296517,
          "text": "Migraine"
        },
        {
          "id": 296518,
          "text": "Deep vein thrombosis"
        },
        {
          "id": 296519,
          "text": "Ischemic stroke"
        }
      ],
      "text": "0ne of the health benefit of the use of combined oral contraceptives in pre-menopausal women is that the Be contraceptives reduce the risk of",
      "unique_key": "Q3877014",
      "question_audio": null,
      "question_video": null,
      "map_id": 34495960,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Ovarian cancer. Combined oral contraceptives (COCs) provide a significant protective effect against ovarian cancer, especially in premenopausal women. The suppression of ovulation reduces the repeated trauma and repair of the ovarian epithelium, which is thought to contribute to carcinogenesis. Studies have shown that the use of COCs reduces the risk of ovarian cancer by up to 50%, with the protective effect persisting for many years after discontinuation. This benefit is particularly valuable in women with a family history of ovarian cancer or those at high risk due to genetic factors (e.g., BRCA mutations). Incorrect Options: B. Migraine: COCs can worsen migraines, particularly those with an aura. Estrogen-containing contraceptives may increase the risk of stroke in women with migraine with aura, making them an unsuitable choice for these patients. C. Deep vein thrombosis (DVT): COCs increase the risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), due to estrogen-induced changes in clotting factors and increased coagulability. This effect is more pronounced in smokers and women over 35 years old. D. Ischemic stroke: COCs increase the risk of ischemic stroke, especially in women with hypertension, smoking habits, or migraine with aura. The estrogen component contributes to an increased thrombogenic potential, making these contraceptives unsuitable for women at high risk of cardiovascular events.",
      "correct_choice_id": 296516,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42544711700144955/42544711700144955.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42544711700144955/42544711700144955.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73818,
      "choices": [
        {
          "id": 296520,
          "text": "Decreased FSH and LH secretion"
        },
        {
          "id": 296521,
          "text": "Ovulation"
        },
        {
          "id": 296522,
          "text": "Hot flushes"
        },
        {
          "id": 296523,
          "text": "Polycystic ovaries"
        }
      ],
      "text": "Clomiphene citrate is not known to produce which of the following effects in a young female of 30 years of age (child bearing aw group)?",
      "unique_key": "Q9880607",
      "question_audio": null,
      "question_video": null,
      "map_id": 34598461,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Decreased FSH and LH secretion. Clomiphene citrate is a selective estrogen receptor modulator (SERM) that acts as an estrogen antagonist in the hypothalamus. It blocks estrogen's negative feedback, leading to an increase in gonadotropin-releasing hormone (GnRH) secretion, which subsequently stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These increased gonadotropin levels promote ovulation, making clomiphene a first-line treatment for anovulatory infertility, particularly in polycystic ovary syndrome (PCOS). Since clomiphene increases FSH and LH secretion, it does not cause a decrease in these hormones, making option A incorrect. Incorrect Options: B. Ovulation: Clomiphene induces ovulation by stimulating FSH and LH secretion, which promotes follicular development and the LH surge necessary for ovulation. This is its primary therapeutic use in treating infertility. C. Hot flushes: Clomiphene can cause hot flushes, similar to those experienced in menopause. This occurs because of its anti-estrogenic effects in the hypothalamus, leading to temperature dysregulation and vasomotor instability. D. Polycystic ovaries: Clomiphene is commonly used to induce ovulation in PCOS patients. However, in some cases, persistent anovulation or excessive follicular stimulation can contribute to the formation of multiple ovarian cysts, leading to an ultrasound appearance resembling polycystic ovaries.",
      "correct_choice_id": 296520,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69803541700144982/69803541700144982.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69803541700144982/69803541700144982.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73819,
      "choices": [
        {
          "id": 296524,
          "text": "Gall stones"
        },
        {
          "id": 296525,
          "text": "Breast cancer"
        },
        {
          "id": 296526,
          "text": "Endometrial carcinoma"
        },
        {
          "id": 296527,
          "text": "Osteoporosis"
        }
      ],
      "text": "Dr. Neelam decides to give estrogen therapy in a postmenopausal woman. The risk of which of the following will not be increased?",
      "unique_key": "Q6101572",
      "question_audio": null,
      "question_video": null,
      "map_id": 34372704,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Osteoporosis. Estrogen therapy in postmenopausal women reduces the risk of osteoporosis by inhibiting osteoclast activity and decreasing bone resorption. Estrogen maintains bone density by promoting osteoblast function and reducing cytokines that activate osteoclasts (such as IL-1, IL-6, and TNF-?). Postmenopausal women experience a drop in estrogen levels, leading to increased bone turnover and bone loss, predisposing them to osteoporosis and fractures. Hormone replacement therapy (HRT) with estrogen helps to preserve bone mineral density (BMD), reducing the risk of osteoporosis and related fractures, making option D incorrect (i.e., estrogen therapy does not increase osteoporosis risk). Incorrect Options: A. Gall stones: Estrogen therapy increases the risk of gallstones by raising cholesterol secretion into bile, leading to bile supersaturation and gallstone formation. This risk is especially high in obese women or those on long-term HRT. B. Breast cancer: Estrogen therapy, particularly when combined with progestins, increases the risk of breast cancer by promoting breast cell proliferation. Studies, such as the Women’s Health Initiative (WHI) trial, have shown that long-term estrogen-progestin therapy raises breast cancer risk, especially in women using it for more than 5 years. C. Endometrial carcinoma: Unopposed estrogen therapy (estrogen without a progestin) increases the risk of endometrial hyperplasia and carcinoma by stimulating endometrial proliferation. To reduce this risk, progestins are added in women with an intact uterus to counteract estrogen's proliferative effects on the endometrium.",
      "correct_choice_id": 296527,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74080471700144997/74080471700144997.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74080471700144997/74080471700144997.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73820,
      "choices": [
        {
          "id": 296528,
          "text": "Spermatogenesis"
        },
        {
          "id": 296529,
          "text": "Prostatic hypertrophy in elderly males"
        },
        {
          "id": 296530,
          "text": "Pubertal changes in the male adolescent"
        },
        {
          "id": 296531,
          "text": "Formation of male external genitalia in the fetus"
        }
      ],
      "text": "The enzyme 5a reductase mediated conversion of testosterone to dihydrotestosterone is NOT required for which of the following actions?",
      "unique_key": "Q8158070",
      "question_audio": null,
      "question_video": null,
      "map_id": 34888773,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Spermatogenesis. Spermatogenesis primarily depends on testosterone, not dihydrotestosterone (DHT). Testosterone, produced by Leydig cells in the testes, acts via androgen receptors in Sertoli cells to support sperm production. Follicle-stimulating hormone (FSH) also plays a role by stimulating Sertoli cells to produce androgen-binding protein (ABP), which helps maintain high intratesticular testosterone levels required for spermatogenesis. Since DHT is not essential for this process, 5α-reductase activity is not required for spermatogenesis, making option A the correct answer. Incorrect Options: B. Prostatic hypertrophy in elderly males: DHT plays a crucial role in benign prostatic hyperplasia (BPH). In elderly men, testosterone is converted to DHT by 5α-reductase in the prostate, where DHT promotes prostate growth and enlargement. This is why 5α-reductase inhibitors (e.g., finasteride, dutasteride) are used to treat BPH, as they reduce DHT levels and prostate size. C. Pubertal changes in the male adolescent: Both testosterone and DHT contribute to male puberty. While testosterone is responsible for muscle growth, deepening of the voice, and spermatogenesis, DHT is required for the development of secondary sexual characteristics such as facial and body hair growth, sebaceous gland activation (leading to acne), and enlargement of the external genitalia. D. Formation of male external genitalia in the fetus: DHT is essential for the development of male external genitalia during fetal life. It is responsible for the differentiation of the genital tubercle into the penis and the labioscrotal folds into the scrotum. 5α-reductase deficiency leads to ambiguous genitalia or undervirilization in male fetuses due to the lack of DHT-mediated masculinization.",
      "correct_choice_id": 296528,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64461461700145027/64461461700145027.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64461461700145027/64461461700145027.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73821,
      "choices": [
        {
          "id": 296532,
          "text": "Have both estrogenic and progestational agonistic activity"
        },
        {
          "id": 296533,
          "text": "Act as agonist in some tissues and antagonist in other tissues"
        },
        {
          "id": 296534,
          "text": "Produces estrogenic effect without binding to estrogen receptors"
        },
        {
          "id": 296535,
          "text": "Inhibits the aromatase enzyme that is required for estrogen synthesis"
        }
      ],
      "text": "The unique property of SERMs is that they",
      "unique_key": "Q4345537",
      "question_audio": null,
      "question_video": null,
      "map_id": 34754451,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Act as agonist in some tissues and antagonist in other tissues. Selective Estrogen Receptor Modulators (SERMs) have a unique dual action, meaning they act as estrogen agonists in some tissues and antagonists in others. This tissue-selective behavior is due to differences in estrogen receptor subtypes (ER? and ER?) and co-regulatory proteins in various tissues. For example: Agonist action: In the bone, SERMs like raloxifene mimic estrogen, helping to prevent osteoporosis by reducing bone resorption. Antagonist action: In the breast, SERMs block estrogen receptors, making them useful in estrogen receptor-positive (ER+) breast cancer treatment (e.g., tamoxifen). This differentiated activity allows SERMs to provide estrogen's beneficial effects (e.g., bone protection) while reducing harmful effects (e.g., breast cancer risk), making them unique among estrogen-related drugs. Incorrect Options: A. Have both estrogenic and progestational agonistic activity: SERMs selectively modulate estrogen receptors only; they do not have progestational activity. Drugs like combined oral contraceptives (COCs) contain both estrogen and progestin, but SERMs do not act as progestins. C. Produce estrogenic effects without binding to estrogen receptors: This is incorrect because SERMs exert their effects by binding directly to estrogen receptors. Their agonistic or antagonistic effects depend on the tissue type and presence of co-regulatory proteins. D. Inhibit the aromatase enzyme that is required for estrogen synthesis: Aromatase inhibitors (e.g., anastrozole, letrozole) work by blocking the conversion of androgens to estrogen, effectively lowering estrogen levels. However, SERMs do not inhibit aromatase; instead, they modulate estrogen receptor activity.",
      "correct_choice_id": 296533,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66710991700145068/66710991700145068.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66710991700145068/66710991700145068.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73822,
      "choices": [
        {
          "id": 296536,
          "text": "Betamethasone"
        },
        {
          "id": 296537,
          "text": "Prednisolone"
        },
        {
          "id": 296538,
          "text": "Cortisol"
        },
        {
          "id": 296539,
          "text": "Hydrocortisone"
        }
      ],
      "text": "Long term steroid therapy can lead to suppression of hypothalamic pituitary-adrenal axis. It can be overcome by using alternate day therapy with corticosteroids. Which of the following steroids are unsuitable for alternate day therapy for such purpose?",
      "unique_key": "Q4582870",
      "question_audio": null,
      "question_video": null,
      "map_id": 34016198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Betamethasone. Betamethasone is unsuitable for alternate-day therapy because it is a long-acting corticosteroid with a prolonged duration of action (36–72 hours). Alternate-day therapy is designed to minimize hypothalamic-pituitary-adrenal (HPA) axis suppression by allowing adrenal recovery on the off day. However, long-acting steroids like betamethasone remain in the system for too long, preventing adequate adrenal recovery, making them unsuitable for this regimen. Incorrect Options: B. Prednisolone: Prednisolone is an intermediate-acting corticosteroid (duration: 12–36 hours), making it suitable for alternate-day therapy. It has a relatively shorter half-life than betamethasone, allowing the HPA axis to recover on the off days. C. Cortisol (Hydrocortisone in its natural form): Cortisol (natural glucocorticoid) is short-acting (8–12 hours) and mimics the body's normal physiological secretion of corticosteroids. Since its effects wear off quickly, it allows for better adrenal recovery, making it suitable for alternate-day therapy. D. Hydrocortisone: Hydrocortisone is a short-acting corticosteroid (8–12 hours), similar to cortisol. Due to its rapid metabolism and clearance, it does not cause prolonged HPA axis suppression, making it appropriate for alternate-day therapy.",
      "correct_choice_id": 296536,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18319301700145124/18319301700145124.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18319301700145124/18319301700145124.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73823,
      "choices": [
        {
          "id": 296540,
          "text": "Cortisol and fludrocortisone"
        },
        {
          "id": 296541,
          "text": "Triamcinolone and dexamethasone"
        },
        {
          "id": 296542,
          "text": "Aldosterone and Fludrocortisone"
        },
        {
          "id": 296543,
          "text": "Dexamethasone and metyrapone"
        }
      ],
      "text": "A 50-year-old man with advanced tuberculosis has developed signs of severe acute adrenal insufficiency. The patient should be treated immediately with a combination of",
      "unique_key": "Q8735858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34837278,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cortisol and Fludrocortisone. Acute adrenal insufficiency (adrenal crisis) is a life-threatening condition characterized by severe hypotension, hypoglycemia, hyponatremia, hyperkalemia, and shock. In this case, the patient has advanced tuberculosis, which is a common cause of primary adrenal insufficiency (Addison’s disease) due to adrenal gland destruction by Mycobacterium tuberculosis. Treatment of acute adrenal insufficiency requires both glucocorticoid and mineralocorticoid replacement: Cortisol (Hydrocortisone) is the preferred glucocorticoid because it has both glucocorticoid and mineralocorticoid activity, helping to restore blood pressure, blood glucose, and electrolyte balance. Fludrocortisone is a potent mineralocorticoid that helps maintain sodium retention and blood pressure by compensating for aldosterone deficiency, which is essential in primary adrenal insufficiency. Thus, cortisol (for immediate stress response) and fludrocortisone (for long-term mineralocorticoid replacement) are the ideal treatment combination. Incorrect Options: B. Triamcinolone and Dexamethasone: Triamcinolone and dexamethasone are purely glucocorticoids and lack mineralocorticoid activity, making them inadequate for treating primary adrenal insufficiency. Mineralocorticoid deficiency must be corrected in these patients to prevent severe hypotension and electrolyte imbalances. C. Aldosterone and Fludrocortisone: Aldosterone is not used as a medication because it has a very short half-life and is not available for therapeutic use. Fludrocortisone alone is insufficient as it lacks glucocorticoid activity, which is essential for managing the stress response and preventing hypoglycemia. D. Dexamethasone and Metyrapone: Dexamethasone is a glucocorticoid but lacks mineralocorticoid activity, making it unsuitable for primary adrenal insufficiency. Metyrapone inhibits cortisol synthesis, which would worsen adrenal insufficiency rather than treat it.",
      "correct_choice_id": 296540,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48331061700145140/48331061700145140.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48331061700145140/48331061700145140.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73824,
      "choices": [
        {
          "id": 296544,
          "text": "They can be administered intravenously"
        },
        {
          "id": 296545,
          "text": "They are more potent"
        },
        {
          "id": 296546,
          "text": "They do not cause Na+ and water retention"
        },
        {
          "id": 296547,
          "text": "They inhibit brain tumors"
        }
      ],
      "text": "Shanti has been diagnosed to have brain tumor. You would prefer to give her betamethasone/dexamethasone over hydrocortisone as steroids is to decrease her cerebral edema because",
      "unique_key": "Q3550629",
      "question_audio": null,
      "question_video": null,
      "map_id": 34628452,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) They do not cause Na+ and water retention. Dexamethasone and betamethasone are preferred over hydrocortisone for reducing cerebral edema in brain tumors because they have minimal mineralocorticoid activity. Hydrocortisone has both glucocorticoid and mineralocorticoid activity, which can cause sodium and water retention, potentially worsening cerebral edema. Dexamethasone and betamethasone are purely glucocorticoids with negligible mineralocorticoid effects, meaning they reduce brain swelling without causing fluid retention. They stabilize the blood-brain barrier, decrease capillary permeability, and reduce vasogenic edema, making them highly effective in managing brain tumor-associated cerebral edema. Incorrect Options: A. They can be administered intravenously: While it is true that both dexamethasone and hydrocortisone can be given intravenously, this is not the primary reason why dexamethasone/betamethasone are preferred for cerebral edema. The key factor is their lack of sodium and water retention, which prevents worsening of cerebral edema. B. They are more potent: Dexamethasone and betamethasone are more potent glucocorticoids than hydrocortisone, but potency alone is not the deciding factor for their use in cerebral edema. The crucial aspect is their lack of mineralocorticoid activity, which prevents fluid retention that could exacerbate brain swelling. D. They inhibit brain tumors: Corticosteroids do not inhibit tumor growth; they only reduce the associated cerebral edema and improve symptoms like headache, nausea, and neurological deficits. Tumor treatment depends on surgery, chemotherapy, or radiation, not steroids.",
      "correct_choice_id": 296546,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35998241700145156/35998241700145156.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35998241700145156/35998241700145156.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73825,
      "choices": [
        {
          "id": 296548,
          "text": "Stop prednisolone"
        },
        {
          "id": 296549,
          "text": "Reduce prednisolone dose to 5 mg/day"
        },
        {
          "id": 296550,
          "text": "Substitute prednisolone with inhaled budesonide"
        },
        {
          "id": 296551,
          "text": "No change/increase in prednisolone dose"
        }
      ],
      "text": "A patient Dharampal has been diagnosed to have bronchial asthma and is maintained on oral prednisolone 20 mg daily and inhaled salbutamol as required. The patient develops chest infection. Which of the following measures would you like to take?",
      "unique_key": "Q4284004",
      "question_audio": null,
      "question_video": null,
      "map_id": 34027327,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) No change/increase in prednisolone dose. In a patient with bronchial asthma on chronic oral corticosteroids (prednisolone 20 mg daily), the development of a chest infection can trigger an asthma exacerbation. During infections or periods of increased stress, the body requires higher levels of corticosteroids to prevent adrenal insufficiency and control worsening airway inflammation. Stopping or reducing prednisolone at this stage could lead to worsening asthma symptoms, increased airway obstruction, and even life-threatening respiratory failure. In such cases, continuing or even increasing the dose of prednisolone is recommended to help manage inflammation and prevent exacerbation. Incorrect Options: A. Stop prednisolone: Abruptly stopping prednisolone in a patient on chronic corticosteroid therapy can lead to adrenal insufficiency, causing hypotension, weakness, and shock. Additionally, stopping steroids during an infection can worsen asthma symptoms due to uncontrolled inflammation. B. Reduce prednisolone dose to 5 mg/day: Reducing the dose during an active infection is dangerous, as the patient may require a higher corticosteroid dose to prevent an asthma exacerbation. A reduction in steroids at this point could lead to worsening lung function and increased respiratory distress. C. Substitute prednisolone with inhaled budesonide: Inhaled corticosteroids (e.g., budesonide) are effective for long-term asthma control but are not sufficient in managing severe cases or systemic inflammation during infections. Oral prednisolone provides systemic effects, which are crucial during infections when asthma control may deteriorate. Budesonide alone would not be adequate to manage a severe asthma exacerbation caused by infection.",
      "correct_choice_id": 296551,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17842761700145175/17842761700145175.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17842761700145175/17842761700145175.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73826,
      "choices": [
        {
          "id": 296552,
          "text": "Hepatotoxicity"
        },
        {
          "id": 296553,
          "text": "Lupus like syndrome"
        },
        {
          "id": 296554,
          "text": "Precocious puberty"
        },
        {
          "id": 296555,
          "text": "Osteoporosis"
        }
      ],
      "text": "Toxic effects of long term administration of a glucocorticoid include",
      "unique_key": "Q7026413",
      "question_audio": null,
      "question_video": null,
      "map_id": 34329800,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Osteoporosis. Long-term glucocorticoid therapy is a well-known cause of osteoporosis due to its negative effects on bone metabolism. Corticosteroids inhibit osteoblast function, increase osteoclast activity, and reduce calcium absorption from the gut, leading to decreased bone mineral density and increased fracture risk. Patients on prolonged glucocorticoid therapy (e.g., prednisolone, dexamethasone) are at high risk of developing osteoporosis and fractures, particularly in weight-bearing bones like the spine and hip. Glucocorticoids also reduce sex hormone levels, contributing to bone loss and further worsening osteoporosis. Preventive measures include calcium and vitamin D supplementation, bisphosphonates (like alendronate), and weight-bearing exercises. Incorrect Options: A. Hepatotoxicity: Glucocorticoids do not typically cause direct liver toxicity. In fact, they are sometimes used to treat liver conditions like autoimmune hepatitis. However, long-term steroid use can lead to fatty liver (hepatic steatosis) or liver enzyme alterations, but not severe hepatotoxicity. B. Lupus-like syndrome: Drug-induced lupus (DILE) is associated with medications like hydralazine, procainamide, and isoniazid, but not glucocorticoids. On the contrary, glucocorticoids are actually used to treat lupus (SLE), not cause it. C. Precocious puberty: Glucocorticoids do not induce precocious puberty. In fact, long-term steroid use can suppress growth and delay puberty by inhibiting the hypothalamic-pituitary-gonadal (HPG) axis. Chronic use can lead to growth retardation in children rather than early puberty.",
      "correct_choice_id": 296555,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44247751700145188/44247751700145188.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44247751700145188/44247751700145188.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73827,
      "choices": [
        {
          "id": 296556,
          "text": "Inhibition of aldosterone synthesis"
        },
        {
          "id": 296557,
          "text": "Suppression of ACTH secretion"
        },
        {
          "id": 296558,
          "text": "Recovery of normal immune function"
        },
        {
          "id": 296559,
          "text": "Prevention of hypoglycemia"
        }
      ],
      "text": "In the treatment of congenital adrenal hyperplasia due to lack of 21 B-hydroxylase, the purpose of administration of a synthetic glucocorticoid is",
      "unique_key": "Q5032164",
      "question_audio": null,
      "question_video": null,
      "map_id": 34656886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Suppression of ACTH secretion. Congenital adrenal hyperplasia (CAH) due to 21?-hydroxylase deficiency results in impaired cortisol synthesis. The lack of cortisol leads to increased secretion of adrenocorticotropic hormone (ACTH) by the pituitary gland, as the hypothalamic-pituitary-adrenal (HPA) axis attempts to compensate. This excess ACTH stimulation causes adrenal hyperplasia and overproduction of adrenal androgens, leading to virilization in females and precocious puberty in males. Glucocorticoid therapy (e.g., hydrocortisone, dexamethasone, or prednisone) is administered to suppress ACTH secretion. By providing exogenous cortisol, the negative feedback mechanism is restored, reducing ACTH levels, decreasing adrenal hyperplasia, and lowering excess androgen production. This helps prevent virilization, early puberty, and abnormal growth patterns in affected children. Incorrect Options: A. Inhibition of aldosterone synthesis: 21?-hydroxylase deficiency can also impair aldosterone production, leading to salt-wasting CAH due to excess sodium loss and dehydration. However, glucocorticoid therapy does not directly inhibit aldosterone synthesis. Instead, mineralocorticoid replacement (e.g., fludrocortisone) is required to treat aldosterone deficiency. C. Recovery of normal immune function: Glucocorticoids are actually immunosuppressive, meaning they do not restore immune function but rather suppress it. CAH is not an immune disorder, so this is not the purpose of glucocorticoid therapy in this condition. D. Prevention of hypoglycemia: Cortisol plays a role in maintaining blood glucose levels, and severe cortisol deficiency can cause hypoglycemia. However, the main goal of glucocorticoid therapy in CAH is to suppress ACTH and reduce androgen excess, not primarily to prevent hypoglycemia.",
      "correct_choice_id": 296557,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27283871700145202/27283871700145202.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27283871700145202/27283871700145202.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73828,
      "choices": [
        {
          "id": 296560,
          "text": "Peptic ulcer"
        },
        {
          "id": 296561,
          "text": "Diabetes mellitus"
        },
        {
          "id": 296562,
          "text": "Hyper tension"
        },
        {
          "id": 296563,
          "text": "Congenital adrenal hyperplasia"
        }
      ],
      "text": "Corticosteroids are used in which of the following disorders is therapy?",
      "unique_key": "Q3181006",
      "question_audio": null,
      "question_video": null,
      "map_id": 34592562,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Congenital adrenal hyperplasia (CAH). Corticosteroids are the mainstay of treatment in congenital adrenal hyperplasia (CAH), particularly in cases caused by 21-hydroxylase deficiency. This disorder results in impaired cortisol synthesis, leading to increased ACTH secretion due to loss of negative feedback. The excess ACTH causes adrenal hyperplasia and overproduction of androgens, resulting in virilization in females and precocious puberty in males. Glucocorticoid therapy (e.g., hydrocortisone, prednisone, dexamethasone) is used to suppress ACTH secretion, reducing adrenal hyperplasia and excess androgen production. In salt-wasting CAH, where aldosterone synthesis is also impaired, mineralocorticoid replacement (fludrocortisone) is required. Without corticosteroid therapy, affected individuals may suffer from adrenal crisis, electrolyte imbalances, and abnormal growth patterns. Incorrect Options: A. Peptic ulcer: Corticosteroids are not used to treat peptic ulcers. In fact, they can exacerbate ulcers by increasing gastric acid secretion and impairing mucosal healing. Chronic corticosteroid use can increase the risk of gastric ulcers, gastrointestinal bleeding, and perforation, especially when combined with NSAIDs. B. Diabetes mellitus: Corticosteroids are not used in diabetes mellitus; instead, they can worsen the condition by increasing blood glucose levels. Glucocorticoids promote hepatic gluconeogenesis and insulin resistance, leading to steroid-induced diabetes in some cases. Therefore, corticosteroids are not a treatment for diabetes but rather a potential risk factor for worsening hyperglycemia. C. Hypertension: Corticosteroids are not used to treat hypertension; rather, they can cause or exacerbate high blood pressure. Glucocorticoids cause sodium and water retention, leading to hypertension and fluid overload. Patients on long-term steroid therapy may develop Cushingoid features, including high blood pressure, weight gain, and hyperglycemia.",
      "correct_choice_id": 296563,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50349081700145217/50349081700145217.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50349081700145217/50349081700145217.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73829,
      "choices": [
        {
          "id": 296564,
          "text": "Heat shock protein 90"
        },
        {
          "id": 296565,
          "text": "Lipocortin"
        },
        {
          "id": 296566,
          "text": "Transcortin"
        },
        {
          "id": 296567,
          "text": "Inhibin"
        }
      ],
      "text": "Hydrocortisone acts as an anti-inflammatory agent because of induction of the synthesis of which of the following protein?",
      "unique_key": "Q6113234",
      "question_audio": null,
      "question_video": null,
      "map_id": 34085667,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Lipocortin. Hydrocortisone (a glucocorticoid) exerts its anti-inflammatory effects primarily by inducing the synthesis of lipocortin (also known as annexin-1). Lipocortin inhibits phospholipase A2, the enzyme responsible for the release of arachidonic acid from membrane phospholipids. By reducing arachidonic acid availability, the production of inflammatory mediators such as prostaglandins and leukotrienes (which are derived from arachidonic acid) is decreased. This suppresses the inflammatory response, reducing swelling, redness, and pain. Additionally, glucocorticoids inhibit the expression of pro-inflammatory genes by interacting with nuclear factor-kappa B (NF-KB) and other transcription factors. Thus, lipocortin plays a crucial role in mediating the anti-inflammatory effects of hydrocortisone and other glucocorticoids. Incorrect Options: A. Heat shock protein 90 (HSP90): HSP90 is a chaperone protein involved in protein folding and stabilization of various signaling molecules, including steroid hormone receptors. While HSP90 assists in glucocorticoid receptor function, it does not directly mediate the anti-inflammatory effects of hydrocortisone. C. Transcortin: Transcortin (also called corticosteroid-binding globulin, CBG) is a plasma protein that binds and transports glucocorticoids in the bloodstream. It regulates the availability of free cortisol but does not have a direct role in inflammation or anti-inflammatory effects. D. Inhibin: Inhibin is a hormone produced by the gonads that inhibits follicle-stimulating hormone (FSH) secretion from the pituitary gland. It plays a role in reproductive physiology but is not related to the anti-inflammatory actions of glucocorticoids.",
      "correct_choice_id": 296565,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57203251700145231/57203251700145231.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57203251700145231/57203251700145231.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73830,
      "choices": [
        {
          "id": 296568,
          "text": "Collecting ducts"
        },
        {
          "id": 296569,
          "text": "Ascending limb of loop of Henle"
        },
        {
          "id": 296570,
          "text": "Proximal convoluted tubule"
        },
        {
          "id": 296571,
          "text": "Early distal convoluted tubule"
        }
      ],
      "text": "Aldosterone is known to cause sodium retention. Its Na+ retaining action is exerted on which part of the nephron?",
      "unique_key": "Q3290852",
      "question_audio": null,
      "question_video": null,
      "map_id": 34329377,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Collecting ducts. Aldosterone, a mineralocorticoid hormone secreted by the adrenal cortex, plays a crucial role in sodium retention and potassium excretion. Aldosterone primarily acts on the principal cells of the collecting ducts in the nephron. It upregulates and activates epithelial sodium channels (ENaCs) on the luminal membrane of collecting duct cells, leading to increased sodium reabsorption. Simultaneously, it promotes the secretion of potassium via renal outer medullary potassium (ROMK) channels and stimulates H+ secretion by intercalated cells. This sodium retention helps in water retention, increasing blood volume and blood pressure. Incorrect Options: B. Ascending limb of the loop of Henle: The thick ascending limb of Henle is responsible for active sodium, potassium, and chloride reabsorption via the Na+/K+/2Cl- co-transporter. However, this process is independent of aldosterone and is instead regulated by factors like loop diuretics and medullary concentration gradients. C. Proximal convoluted tubule (PCT): The PCT is responsible for the bulk of sodium reabsorption (~65-70%). Sodium is reabsorbed here via Na+/H+ exchangers, Na+-glucose co-transporters, and Na+/K+ ATPase pumps, but this process does not involve aldosterone regulation. D. Early distal convoluted tubule: The early distal tubule is responsible for sodium reabsorption via the Na+/Cl- symporter and is the target of thiazide diuretics. Aldosterone has minimal direct action on this part of the nephron. Instead, it primarily acts on the late distal tubule and collecting ducts, where it enhances sodium reabsorption.",
      "correct_choice_id": 296568,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43058671700145243/43058671700145243.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43058671700145243/43058671700145243.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73831,
      "choices": [
        {
          "id": 296572,
          "text": "Easy bruising"
        },
        {
          "id": 296573,
          "text": "Increased growth of hairs"
        },
        {
          "id": 296574,
          "text": "Hypopigmentation"
        },
        {
          "id": 296575,
          "text": "Delayed wound healing"
        }
      ],
      "text": "Following adverse effects are seen on use of topical corticosteroids except",
      "unique_key": "Q9623950",
      "question_audio": null,
      "question_video": null,
      "map_id": 34799276,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Increased growth of hairs. Topical corticosteroids do not commonly cause increased hair growth (hypertrichosis); instead, they are more likely to cause skin atrophy, thinning, and other dermal changes. While systemic corticosteroids can sometimes lead to hirsutism, this is not a well-documented effect of topical corticosteroid use. The primary adverse effects of topical corticosteroids occur locally, especially with prolonged or excessive use, and include skin thinning, hypopigmentation, telangiectasia, striae, and delayed wound healing. Explanation of Incorrect Options: (A) Easy bruising: Incorrect because topical corticosteroids cause skin atrophy by inhibiting fibroblast function, leading to weaker dermal structure. As a result, blood vessels become more fragile, increasing susceptibility to bruising (purpura and ecchymosis), especially in elderly individuals or those using high-potency steroids over a long period. (C) Hypopigmentation: Incorrect as topical corticosteroids suppress melanocyte activity, leading to localized hypopigmentation. This is more noticeable in darker-skinned individuals and is commonly seen with prolonged use. (D) Delayed wound healing: Incorrect because corticosteroids inhibit inflammatory responses and collagen synthesis, both of which are essential for wound healing. This effect reduces new tissue formation, leading to delayed healing and increased risk of infections.",
      "correct_choice_id": 296573,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20770911700146254/20770911700146254.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20770911700146254/20770911700146254.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73832,
      "choices": [
        {
          "id": 296576,
          "text": "Hydrocortisone"
        },
        {
          "id": 296577,
          "text": "Betamethasone"
        },
        {
          "id": 296578,
          "text": "Prednisolone"
        },
        {
          "id": 296579,
          "text": "Cortisol"
        }
      ],
      "text": "Which of the following glucocorticoid has half-life between 12-36 hours",
      "unique_key": "Q4296967",
      "question_audio": null,
      "question_video": null,
      "map_id": 34680154,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Prednisolone. Prednisolone is a synthetic glucocorticoid with a half-life of approximately 12-36 hours, classifying it as an intermediate-acting corticosteroid. It is commonly used for inflammatory, allergic, and autoimmune disorders due to its potent anti-inflammatory and immunosuppressive effects. Unlike short-acting corticosteroids (such as hydrocortisone) or long-acting corticosteroids (such as betamethasone), prednisolone provides a balance between duration of action and side effects, making it suitable for chronic conditions requiring moderate glucocorticoid activity. Explanation of Incorrect Options: (A) Hydrocortisone: Incorrect because hydrocortisone (cortisol) is a short-acting glucocorticoid with a half-life of about 8-12 hours. It mimics the natural cortisol secreted by the adrenal glands and is used for adrenal insufficiency and stress dose management. (B) Betamethasone: Incorrect as betamethasone is a long-acting glucocorticoid with a half-life greater than 36 hours. Due to its prolonged action, it is used in fetal lung maturation in preterm labor and severe inflammatory conditions where a sustained anti-inflammatory effect is needed. (D) Cortisol: Incorrect because cortisol is the natural glucocorticoid secreted by the adrenal glands, and its half-life is around 8-12 hours, making it a short-acting glucocorticoid similar to hydrocortisone.",
      "correct_choice_id": 296578,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16570921700146306/16570921700146306.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16570921700146306/16570921700146306.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73833,
      "choices": [
        {
          "id": 296580,
          "text": "Sodium and water retention"
        },
        {
          "id": 296581,
          "text": "Oedema"
        },
        {
          "id": 296582,
          "text": "The progressive rise in BP"
        },
        {
          "id": 296583,
          "text": "Hyperkalemic alkalosis"
        }
      ],
      "text": "Following adverse effects are seen with the use of mineralocorticoids except",
      "unique_key": "Q6618966",
      "question_audio": null,
      "question_video": null,
      "map_id": 34282046,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hyperkalemic alkalosis. This statement is incorrect because mineralocorticoids, such as aldosterone and fludrocortisone, do not cause hyperkalemia but rather lead to hypokalemia and metabolic alkalosis. Mineralocorticoids act on the distal convoluted tubule and collecting ducts of the kidney to promote sodium and water retention while enhancing potassium and hydrogen ion excretion. This results in hypokalemia (low potassium levels) and metabolic alkalosis (due to loss of hydrogen ions). Since mineralocorticoids cause hypokalemia, hyperkalemia (elevated potassium levels) does not occur, making this option incorrect. Explanation of Incorrect Options: (A) Sodium and water retention: Correct statement. Mineralocorticoids increase sodium reabsorption from the renal tubules, leading to water retention. This contributes to expansion of extracellular fluid volume, which is a characteristic effect of excessive mineralocorticoid activity. (B) Oedema: Correct statement. Due to fluid retention caused by sodium reabsorption, mineralocorticoids can lead to peripheral and generalized oedema. This is commonly seen in conditions like primary hyperaldosteronism (Conn’s syndrome) or in patients receiving excessive doses of fludrocortisone. (C) The progressive rise in BP: Correct statement. The increased sodium and water retention leads to an expanded blood volume, causing hypertension. Persistent mineralocorticoid excess is associated with chronic high blood pressure, which can lead to cardiovascular complications.",
      "correct_choice_id": 296583,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47483751700146318/47483751700146318.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47483751700146318/47483751700146318.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73834,
      "choices": [
        {
          "id": 296584,
          "text": "Norgestrel 3 mg Ethinylestradiol 30 micrograms"
        },
        {
          "id": 296585,
          "text": "Norgestrel 0.3 mg Ethinylestradiol 50 micrograms"
        },
        {
          "id": 296586,
          "text": "Norgestrel 5 mg Ethinylestradiol 50 micrograms"
        },
        {
          "id": 296587,
          "text": "Norgestrel 0.5 mg Ethinylestradiol 30 micrograms"
        }
      ],
      "text": "MALA D contains",
      "unique_key": "Q4510233",
      "question_audio": null,
      "question_video": null,
      "map_id": 34211871,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Norgestrel 0.5 mg + Ethinylestradiol 30 micrograms. MALA D is an oral contraceptive pill provided under the National Family Welfare Program in India. It contains 0.5 mg of Norgestrel (a progestin) and 30 micrograms of Ethinylestradiol (an estrogen), making it a combined oral contraceptive (COC). The combination of estrogen and progestin prevents ovulation, thickens cervical mucus to inhibit sperm penetration, and alters the endometrial lining to prevent implantation. MALA D is widely used due to its affordability, effectiveness, and minimal side effects when taken correctly. Explanation of Incorrect Options: (A) Norgestrel 3 mg + Ethinylestradiol 30 micrograms: Incorrect because MALA D contains only 0.5 mg of Norgestrel, not 3 mg. A higher dose of progestin like 3 mg is not typically used in standard combined oral contraceptive pills, as it would increase the risk of side effects like irregular bleeding and androgenic effects. (B) Norgestrel 0.3 mg + Ethinylestradiol 50 micrograms: Incorrect because MALA D contains 0.5 mg of Norgestrel and 30 micrograms of Ethinylestradiol, not 0.3 mg and 50 micrograms, respectively. A higher estrogen dose (50 mcg) is associated with increased risks of thromboembolism and is generally not preferred in modern contraceptive formulations. (C) Norgestrel 5 mg + Ethinylestradiol 50 micrograms: Incorrect because this dose is excessively high compared to the standard MALA D composition. Such a high dose of Norgestrel (5 mg) is not used in regular contraception and could lead to severe hormonal imbalances and adverse effects like nausea, bloating, and menstrual irregularities.",
      "correct_choice_id": 296587,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40118921700146385/40118921700146385.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40118921700146385/40118921700146385.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73835,
      "choices": [
        {
          "id": 296588,
          "text": "Levonorgestrel"
        },
        {
          "id": 296589,
          "text": "Ulipristal"
        },
        {
          "id": 296590,
          "text": "Desogestrel"
        },
        {
          "id": 296591,
          "text": "IUCD"
        }
      ],
      "text": "All are emergency contraceptive except",
      "unique_key": "Q4066682",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985653,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Desogestrel. Desogestrel is not used as an emergency contraceptive (EC); rather, it is a progestin used in regular oral contraceptive pills (OCPs), including progestin-only pills (POPs). Emergency contraception requires drugs or devices that can delay ovulation, prevent fertilization, or inhibit implantation when taken after unprotected intercourse. Desogestrel is not approved or effective for emergency contraception and is instead used for continuous daily contraception. Explanation of Incorrect Options: (A) Levonorgestrel: Incorrect because levonorgestrel is a widely used emergency contraceptive. It is available as a single-dose (1.5 mg) or two-dose regimen (0.75 mg twice, 12 hours apart) and works primarily by inhibiting or delaying ovulation if taken within 72 hours of unprotected sex. (B) Ulipristal: Incorrect because ulipristal acetate (30 mg) is an emergency contraceptive that acts as a selective progesterone receptor modulator (SPRM). It is effective up to 120 hours (5 days) after unprotected intercourse and works by delaying ovulation. It has a higher efficacy compared to levonorgestrel, especially closer to ovulation. (D) IUCD (Intrauterine Copper Device): Incorrect because the copper intrauterine device (Cu-IUCD) is one of the most effective forms of emergency contraception. It can be inserted within 5 days of unprotected intercourse and works by creating a spermicidal environment in the uterus, preventing fertilization and implantation. Additionally, it provides long-term contraception if left in place.",
      "correct_choice_id": 296590,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26664761700146544/26664761700146544.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26664761700146544/26664761700146544.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73836,
      "choices": [
        {
          "id": 296592,
          "text": "Fulvestrant"
        },
        {
          "id": 296593,
          "text": "Raloxifene"
        },
        {
          "id": 296594,
          "text": "Tamoxifen"
        },
        {
          "id": 296595,
          "text": "Clomiphene"
        }
      ],
      "text": "Which of the following drugs is used in metastatic breast carcinoma in premenopausal women",
      "unique_key": "Q6188497",
      "question_audio": null,
      "question_video": null,
      "map_id": 34615711,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Tamoxifen. Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used for the treatment of metastatic breast carcinoma, particularly in premenopausal women. It acts as an estrogen antagonist in breast tissue, inhibiting the growth of estrogen receptor (ER)-positive breast cancer cells by blocking the binding of estrogen. Since premenopausal women have active ovarian estrogen production, tamoxifen is an effective first-line hormonal therapy for ER-positive breast cancer, helping to slow disease progression and improve survival rates. Explanation of Incorrect Options: (A) Fulvestrant: Incorrect because fulvestrant is a selective estrogen receptor degrader (SERD) that works by downregulating and degrading estrogen receptors. While effective in ER-positive breast cancer, it is primarily used in postmenopausal women or in premenopausal women after ovarian suppression (e.g., with GnRH analogs). It is not a preferred first-line option for premenopausal metastatic breast cancer. (B) Raloxifene: Incorrect because raloxifene is a SERM primarily used for osteoporosis prevention and treatment, as well as breast cancer risk reduction in postmenopausal women. It has estrogen antagonist effects on breast tissue but is not approved for treating metastatic breast cancer in premenopausal women. (D) Clomiphene: Incorrect because clomiphene is an ovulation-inducing agent used for infertility treatment in women with anovulation (e.g., in PCOS). It works by blocking estrogen receptors in the hypothalamus, leading to increased secretion of gonadotropins (FSH and LH). It has no role in the treatment of metastatic breast carcinoma.",
      "correct_choice_id": 296594,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25209641700146555/25209641700146555.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25209641700146555/25209641700146555.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73837,
      "choices": [
        {
          "id": 296596,
          "text": "To be taken once daily for 5 days starting from the 5th day of the cycle"
        },
        {
          "id": 296597,
          "text": "Daily dose needs to be doubled. If 2-3 months of treatment does not result in conception"
        },
        {
          "id": 296598,
          "text": "It can be tried up to one year and not more than that"
        },
        {
          "id": 296599,
          "text": "All of the above"
        }
      ],
      "text": "Which of the following is correct regarding the treatment of infertility with clomiphene",
      "unique_key": "Q1795036",
      "question_audio": null,
      "question_video": null,
      "map_id": 34315361,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above. Clomiphene is a selective estrogen receptor modulator (SERM) used to induce ovulation in women with anovulatory infertility, such as in polycystic ovary syndrome (PCOS). It works by blocking estrogen receptors in the hypothalamus, leading to increased release of gonadotropins (FSH and LH), which stimulate follicular development and ovulation. (A) To be taken once daily for 5 days starting from the 5th day of the cycle: Correct. Clomiphene therapy typically begins on the 5th day of the menstrual cycle and is taken for 5 consecutive days (usually at a dose of 50 mg once daily). This regimen is designed to stimulate follicular development and induce ovulation in women with irregular or absent ovulation. (B) Daily dose needs to be doubled if 2-3 months of treatment does not result in conception: Correct. If ovulation does not occur at 50 mg, the dose can be increased to 100 mg/day in subsequent cycles. However, if ovulation occurs but pregnancy does not, further investigations may be needed to assess additional factors contributing to infertility. (C) It can be tried up to one year and not more than that: Correct. Clomiphene should not be used for more than 12 cycles because prolonged use may increase the risk of ovarian hyperstimulation, multiple pregnancies, and ovarian cancer. If pregnancy is not achieved within a year, alternative fertility treatments like gonadotropin therapy or assisted reproductive techniques (ART) such as in vitro fertilization (IVF) may be considered. Explanation of Incorrect Options: Since all the statements are correct, none of the individual options are incorrect. Therefore, the best choice is (D) All of the above, as all statements accurately describe the clinical use of clomiphene in infertility treatment.",
      "correct_choice_id": 296599,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22521091700146576/22521091700146576.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22521091700146576/22521091700146576.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73838,
      "choices": [
        {
          "id": 296600,
          "text": "Hepatoma"
        },
        {
          "id": 296601,
          "text": "Endometrial cancer"
        },
        {
          "id": 296602,
          "text": "Breast Cancer"
        },
        {
          "id": 296603,
          "text": "Carcinoma of gallbladder"
        }
      ],
      "text": "Women receiving estrogen therapy have an increased risk of developing all the following except",
      "unique_key": "Q3731364",
      "question_audio": null,
      "question_video": null,
      "map_id": 34579367,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Carcinoma of the gallbladder. Estrogen therapy is not directly associated with an increased risk of gallbladder cancer. While estrogen therapy can lead to gallstone formation by altering bile composition and reducing gallbladder motility, its role in gallbladder cancer development has not been well established. Gallbladder carcinoma is more commonly linked to chronic gallstone disease, chronic inflammation, and genetic predisposition rather than estrogen therapy. Explanation of Incorrect Options: (A) Hepatoma (Hepatocellular carcinoma - HCC): Correct association. Estrogen therapy has been linked to hepatic adenomas, which are benign liver tumors. Long-term estrogen use, particularly in oral contraceptives or hormone replacement therapy (HRT), increases the risk of hepatic adenomas, which may occasionally transform into hepatocellular carcinoma (HCC). (B) Endometrial cancer: Correct association. Unopposed estrogen therapy (without progesterone) significantly increases the risk of endometrial hyperplasia and cancer. Estrogen stimulates endometrial proliferation, and without the balancing effect of progesterone, prolonged exposure can lead to malignant transformation. This is why combined estrogen-progesterone therapy is recommended for women with an intact uterus undergoing hormone replacement therapy (HRT). (C) Breast cancer: Correct association. Estrogen therapy, particularly combined estrogen-progesterone therapy, is associated with an increased risk of breast cancer. Estrogens promote the growth and division of estrogen receptor-positive (ER+) breast cancer cells. Studies have shown that long-term use of hormone replacement therapy (HRT), particularly combined HRT, modestly increases the risk of breast cancer.",
      "correct_choice_id": 296603,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77135171700146602/77135171700146602.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77135171700146602/77135171700146602.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73839,
      "choices": [
        {
          "id": 296604,
          "text": "Sildenafil: used in pulmonary hypertension"
        },
        {
          "id": 296605,
          "text": "Finasteride: approved in male pattern baldness"
        },
        {
          "id": 296606,
          "text": "Goserelin also approved for ovarian cancer"
        },
        {
          "id": 296607,
          "text": "Flutamide: used in Hirsutism in females"
        }
      ],
      "text": "Identify the wrong match",
      "unique_key": "Q2645650",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684037,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Goserelin also approved for ovarian cancer. Goserelin is a GnRH (gonadotropin-releasing hormone) agonist that is primarily used for the treatment of prostate cancer, breast cancer (hormone-sensitive), endometriosis, and uterine fibroids. However, it is not a standard approved treatment for ovarian cancer. Ovarian cancer is typically treated with surgical debulking and chemotherapy (e.g., platinum-based agents like cisplatin and paclitaxel), rather than GnRH agonists. Explanation of Incorrect Options: (A) Sildenafil: used in pulmonary hypertension – Correct match. Sildenafil is a PDE-5 (phosphodiesterase type 5) inhibitor that enhances nitric oxide-mediated vasodilation. It is approved for pulmonary arterial hypertension (PAH) under the brand name Revatio and helps reduce pulmonary arterial pressure by promoting vasodilation. It is also widely used for erectile dysfunction under the brand name Viagra. (B) Finasteride: approved in male pattern baldness – Correct match. Finasteride is a 5-alpha reductase inhibitor that reduces the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for androgenic alopecia (male pattern baldness). It is approved at 1 mg/day for male pattern baldness and at 5 mg/day for benign prostatic hyperplasia (BPH). (D) Flutamide: used in hirsutism in females – Correct match. Flutamide is a nonsteroidal anti-androgen that blocks androgen receptors, thereby reducing androgenic effects like excessive hair growth (hirsutism) in females. It is sometimes used off-label for treating hirsutism in conditions such as polycystic ovary syndrome (PCOS). However, it has been largely replaced by safer anti-androgens like spironolactone due to concerns about hepatotoxicity.",
      "correct_choice_id": 296606,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53294171700146616/53294171700146616.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53294171700146616/53294171700146616.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73840,
      "choices": [
        {
          "id": 296608,
          "text": "Block the conversion of testosterone to dihydrotestosterone"
        },
        {
          "id": 296609,
          "text": "Impotence is not seen with the use of these drugs"
        },
        {
          "id": 296610,
          "text": "Finasteride also is approved for use in the treatment of male pattern baldness"
        },
        {
          "id": 296611,
          "text": "Finasteride is an effective as flutamide and the combination of estrogen and cyproterone in the treatment of hirsutism"
        }
      ],
      "text": "Following are true about 5alpha-Reductase inhibitors except",
      "unique_key": "Q7035437",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566409,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Impotence is not seen with the use of these drugs. 5?-Reductase inhibitors, such as finasteride and dutasteride, can cause sexual side effects, including impotence (erectile dysfunction), decreased libido, and ejaculatory dysfunction. These effects occur because the drugs reduce dihydrotestosterone (DHT) levels, which play a key role in sexual function and libido. Therefore, the statement that impotence is not seen is incorrect. Explanation of Incorrect Options: (A) Block the conversion of testosterone to dihydrotestosterone – Correct statement. 5?-Reductase inhibitors inhibit the enzyme 5?-reductase, which converts testosterone into its more potent androgenic form, dihydrotestosterone (DHT). This helps in conditions like benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness), where DHT plays a significant role in disease progression. (C) Finasteride also is approved for use in the treatment of male pattern baldness – Correct statement. Finasteride is FDA-approved at a dose of 1 mg/day for treating androgenic alopecia (male pattern baldness) because it reduces scalp DHT levels, thereby slowing hair loss and promoting regrowth. The 5 mg/day dose is used for BPH. (D) Finasteride is as effective as flutamide and the combination of estrogen and cyproterone in the treatment of hirsutism – Correct statement. Studies have shown that finasteride is comparable to flutamide (an androgen receptor antagonist) and cyproterone (a progestin with anti-androgen effects) in treating hirsutism by reducing DHT levels, which contributes to excess hair growth in females. It is used as an off-label treatment for hirsutism, especially in conditions like polycystic ovary syndrome (PCOS).",
      "correct_choice_id": 296609,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62299771700146628/62299771700146628.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62299771700146628/62299771700146628.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73841,
      "choices": [
        {
          "id": 296612,
          "text": "Continue with the course without regard to the missed dose"
        },
        {
          "id": 296613,
          "text": "Discontinue the course and use alternative method of contraception"
        },
        {
          "id": 296614,
          "text": "Take 2 pills every day for the remaining part of the course"
        },
        {
          "id": 296615,
          "text": "Take 2 pills the next day and continue with the course"
        }
      ],
      "text": "A patient parul gives you the history that the has missed a single dose of her combined oral contraceptive pill. Which of the following will you advise her?",
      "unique_key": "Q8471352",
      "question_audio": null,
      "question_video": null,
      "map_id": 34485923,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Take 2 pills the next day and continue with the course. If a patient misses a single dose of a combined oral contraceptive pill (COCP), the standard recommendation is to take the missed pill as soon as possible, even if it means taking two pills on the same day. This ensures that hormone levels are maintained, reducing the risk of ovulation and unintended pregnancy. After taking the missed dose, the patient should continue with the rest of the pack as usual without any additional contraceptive measures. Explanation of Incorrect Options: (A) Continue with the course without regard to the missed dose – Incorrect. If a pill is missed and not taken, hormone levels may drop, increasing the risk of ovulation and reducing contraceptive efficacy. The proper protocol is to take the missed pill as soon as possible. Simply continuing the course without compensating for the missed dose may increase the risk of pregnancy. (B) Discontinue the course and use an alternative method of contraception – Incorrect. Stopping the entire course of COCPs due to a single missed dose is unnecessary and incorrect. Doing so could lead to irregular bleeding and an increased risk of pregnancy if unprotected intercourse occurs. The appropriate approach is to continue the pills while correcting for the missed dose rather than abandoning the course. (C) Take 2 pills every day for the remaining part of the course – Incorrect. Taking 2 pills every day for the rest of the course is not required and could increase the risk of side effects such as nausea, headaches, and hormonal imbalance. Only one extra pill is needed on the day after the missed dose, and the regular dosing schedule should be maintained thereafter.",
      "correct_choice_id": 296615,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42804851700147050/42804851700147050.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42804851700147050/42804851700147050.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73842,
      "choices": [
        {
          "id": 296616,
          "text": "Clomiphene citrate"
        },
        {
          "id": 296617,
          "text": "Danazol"
        },
        {
          "id": 296618,
          "text": "Mifepristone"
        },
        {
          "id": 296619,
          "text": "Medroxyprogesterone acetate"
        }
      ],
      "text": "A young female Shagun comes to you in the gynaecology OPD and gives the history that she had intercourse with her boyfriend 5 hours back Select the drug that can act as a single dose postcoital contraceptive for her",
      "unique_key": "Q4921253",
      "question_audio": null,
      "question_video": null,
      "map_id": 34399330,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Mifepristone. Mifepristone (a progesterone receptor antagonist) is an effective postcoital contraceptive that can be used as a single-dose emergency contraceptive pill (ECP). It works by preventing implantation if taken within 120 hours (5 days) of unprotected intercourse. Additionally, mifepristone inhibits ovulation if administered before the luteinizing hormone (LH) surge, making it highly effective in preventing pregnancy. A low dose of mifepristone (10 mg) is often used for emergency contraception. Explanation of Incorrect Options: (A) Clomiphene citrate – Incorrect. Clomiphene citrate is a selective estrogen receptor modulator (SERM) that is used to induce ovulation in women with anovulatory infertility. It does not have any role in postcoital contraception and cannot prevent pregnancy after unprotected intercourse. (B) Danazol – Incorrect. Danazol is an androgenic steroid used for conditions like endometriosis and fibrocystic breast disease, but it does not work as an emergency contraceptive. It does not prevent implantation or ovulation effectively when used postcoitally. (D) Medroxyprogesterone acetate – Incorrect. Medroxyprogesterone acetate is a long-acting progestin used for contraception in the form of depot injections (DMPA), but it is not suitable as an emergency contraceptive. It works by inhibiting ovulation over an extended period rather than acting rapidly to prevent pregnancy after unprotected intercourse.",
      "correct_choice_id": 296618,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11003041700147142/11003041700147142.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11003041700147142/11003041700147142.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73843,
      "choices": [
        {
          "id": 296620,
          "text": "Blocks the increased risk of myocardial infarction due to estrogen"
        },
        {
          "id": 296621,
          "text": "Enhances the metabolic benefits of estrogen treatment"
        },
        {
          "id": 296622,
          "text": "Enhances the metabolic benefits of estrogen treatment"
        },
        {
          "id": 296623,
          "text": "Blocks the increased risk of endometrial carcinoma due to estrogen"
        }
      ],
      "text": "Dr. Shweta decided to add a progestin for 10-12 days each month to estrogen replacement therapy in menopausal women in the gynecology OPD. Addition of progestin is recommended because the progestin",
      "unique_key": "Q7557254",
      "question_audio": null,
      "question_video": null,
      "map_id": 34969740,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Blocks the increased risk of endometrial carcinoma due to estrogen. In menopausal hormone therapy (MHT), estrogen replacement therapy (ERT) alone can lead to endometrial hyperplasia and increase the risk of endometrial carcinoma in women with an intact uterus. This happens because unopposed estrogen stimulates continuous proliferation of the endometrial lining. To counter this effect, progestin is added for 10-12 days each month to induce secretory changes in the endometrium, preventing hyperplasia and reducing the risk of endometrial cancer. This combination is called combined estrogen-progestin therapy (EPT) and is the preferred regimen for women with a uterus. Explanation of Incorrect Options: (A) Blocks the increased risk of myocardial infarction due to estrogen – Incorrect. Estrogen has both beneficial and harmful cardiovascular effects. While it helps maintain favorable lipid profiles (increasing HDL, decreasing LDL), it can also promote thrombosis and increase clotting factors, raising the risk of myocardial infarction (MI) and stroke. However, progestins do not block this risk; in fact, certain progestins may even negatively impact cardiovascular health by reducing the beneficial effects of estrogen on lipid metabolism. (B) Enhances the metabolic benefits of estrogen treatment – Incorrect. Estrogen therapy provides several metabolic benefits, such as improving bone density, lipid profile, and insulin sensitivity. However, progestins do not enhance these effects. In some cases, certain progestins may counteract estrogen’s metabolic benefits by negatively affecting lipid metabolism and glucose tolerance. (C) Enhances the metabolic benefits of estrogen treatment – Incorrect (Duplicate Option). This is a repetition of Option B and remains incorrect for the same reasons. Progestins do not enhance the metabolic benefits of estrogen.",
      "correct_choice_id": 296623,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69759281700147156/69759281700147156.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69759281700147156/69759281700147156.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73844,
      "choices": [
        {
          "id": 296624,
          "text": "Weight gain"
        },
        {
          "id": 296625,
          "text": "Osteoporosis"
        },
        {
          "id": 296626,
          "text": "Venous thrombosis"
        },
        {
          "id": 296627,
          "text": "Hot flushes and sweating"
        }
      ],
      "text": "Which of the following is not the side effect of tamoxifen:",
      "unique_key": "Q5087814",
      "question_audio": null,
      "question_video": null,
      "map_id": 34451065,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Osteoporosis Which is not a side effect of tamoxifen. Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an estrogen antagonist in breast tissue (hence its use in estrogen receptor-positive breast cancer) but as a partial estrogen agonist in bone and endometrium. This estrogenic activity in bones helps preserve bone mineral density (BMD), reducing the risk of osteoporosis. In fact, tamoxifen can help prevent osteoporosis in postmenopausal women by maintaining bone strength. This distinguishes it from aromatase inhibitors like anastrozole and letrozole, which increase osteoporosis risk due to their complete estrogen blockade. Explanation of Incorrect Options: Option A: Weight gain (Incorrect) Weight gain is a commonly reported side effect of tamoxifen, though the exact mechanism is unclear. It is thought to be related to hormonal changes and fluid retention rather than a direct effect on metabolism. Many patients on tamoxifen experience weight fluctuations, making this a valid side effect. Option C: Venous thrombosis (Incorrect) Tamoxifen has estrogen-like effects on the liver, leading to increased synthesis of coagulation factors (such as fibrinogen), which raises the risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). The risk is especially high in women with predisposing factors like immobility, obesity, or a history of clotting disorders. Option D: Hot flushes and sweating (Incorrect) Hot flushes and sweating are common menopausal-like side effects of tamoxifen due to its anti-estrogenic action in the hypothalamus, which disrupts thermoregulation. This is a well-documented side effect, affecting a significant number of patients on tamoxifen therapy.",
      "correct_choice_id": 296625,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62790651700318716/62790651700318716.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62790651700318716/62790651700318716.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73845,
      "choices": [
        {
          "id": 296628,
          "text": "Tamoxifen"
        },
        {
          "id": 296629,
          "text": "Cyproterone"
        },
        {
          "id": 296630,
          "text": "Testosterone"
        },
        {
          "id": 296631,
          "text": "Chlorambucil"
        }
      ],
      "text": "Drug useful in breast cancer is:",
      "unique_key": "Q5934769",
      "question_audio": null,
      "question_video": null,
      "map_id": 34806515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Tamoxifen Which is a selective estrogen receptor modulator (SERM) widely used in the treatment and prevention of estrogen receptor-positive (ER+) breast cancer. Tamoxifen acts as an estrogen antagonist in breast tissue, preventing estrogen from stimulating cancer cell growth. However, it has partial agonist activity in other tissues, such as bone and the endometrium, which can help preserve bone density but may also increase the risk of endometrial hyperplasia and cancer. Tamoxifen is commonly used in premenopausal and postmenopausal women with ER+ breast cancer, as well as for breast cancer prevention in high-risk women. Explanation of Incorrect Options: Option B: Cyproterone (Incorrect) Cyproterone is an anti-androgen and progestin used in conditions like hirsutism, prostate cancer, and hypersexuality disorders, but it has no role in the treatment of breast cancer. Unlike tamoxifen, cyproterone does not block estrogen receptors, making it ineffective for ER+ breast cancer. Option C: Testosterone (Incorrect) Testosterone is an androgen and is not used in breast cancer treatment. In fact, high androgen levels can be converted into estrogens via aromatase, potentially worsening hormone-sensitive breast cancer. While androgen receptor modulation is an area of research, testosterone itself is not a standard therapy for breast cancer. Option D: Chlorambucil (Incorrect) Chlorambucil is an alkylating agent used in the treatment of chronic lymphocytic leukemia (CLL) and certain lymphomas, but it is not a first-line drug for breast cancer. While some alkylating agents like cyclophosphamide are used in breast cancer treatment (e.g., in combination regimens like CMF—Cyclophosphamide, Methotrexate, and 5-FU), chlorambucil is not a standard option for breast cancer management.",
      "correct_choice_id": 296628,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61945401700318785/61945401700318785.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61945401700318785/61945401700318785.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73846,
      "choices": [
        {
          "id": 296632,
          "text": "Cardiovascular collapse (adrenal crisis)"
        },
        {
          "id": 296633,
          "text": "Osteoporosis"
        },
        {
          "id": 296634,
          "text": "Increased risk of infection"
        },
        {
          "id": 296635,
          "text": "Insomnia (short-term oral/parenteral)"
        }
      ],
      "text": "A 39-year-old kidney transplant recipient presents to her treating physician for follow-up. Among other immunosuppressant drugs, she has been taking daily prednisone for the past 2 months since her transplant. With only a few doses of prednisone left, she gets snowed into her house and cannot refill her prescription (but she has enough of the other medications to last a few more weeks). If she runs out of prednisone and cannot get it refilled, what is she most at risk for developing?",
      "unique_key": "Q5954471",
      "question_audio": null,
      "question_video": null,
      "map_id": 34851497,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cardiovascular collapse (adrenal crisis) Explanation for the Correct Answer: Long-term use of exogenous corticosteroids like prednisone suppresses the hypothalamic-pituitary-adrenal (HPA) axis via negative feedback. This leads to adrenal atrophy, as the adrenal glands stop producing cortisol due to prolonged suppression by exogenous steroids. If prednisone is suddenly stopped, the body is unable to rapidly produce sufficient cortisol, leading to acute adrenal insufficiency (adrenal crisis). Symptoms include: Severe hypotension and cardiovascular collapse (due to lack of cortisol’s role in maintaining vascular tone) Hypoglycemia Nausea, vomiting, abdominal pain Lethargy, weakness, confusion This condition is life-threatening and requires immediate treatment with intravenous hydrocortisone and fluids. Thus, sudden withdrawal of prednisone puts the patient at high risk for adrenal crisis, making cardiovascular collapse (A) the correct answer. Explanation for the Incorrect Answers: (B) Osteoporosis – Incorrect Chronic corticosteroid use does increase the risk of osteoporosis by inhibiting bone formation and increasing resorption. However, this effect develops gradually over months to years. Stopping prednisone abruptly does not cause an immediate risk of osteoporosis-related complications. (C) Increased risk of infection – Incorrect Corticosteroids suppress the immune system, increasing the risk of infections. However, suddenly stopping steroids does not immediately increase infection risk—instead, it restores immune function over time. The immediate danger is adrenal crisis, not infection. (D) Insomnia (short-term oral/parenteral) – Incorrect Corticosteroids can cause insomnia and agitation, especially when given at higher doses. However, withdrawal from steroids is more commonly associated with fatigue, depression, and adrenal insufficiency, rather than insomnia. Insomnia is not the most critical risk compared to adrenal crisis.",
      "correct_choice_id": 296632,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7969021700305010/7969021700305010.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7969021700305010/7969021700305010.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73847,
      "choices": [
        {
          "id": 296636,
          "text": "Hypoglycemia"
        },
        {
          "id": 296637,
          "text": "Osteoporosis"
        },
        {
          "id": 296638,
          "text": "Hypotension"
        },
        {
          "id": 296639,
          "text": "Hyperkalemia"
        }
      ],
      "text": "A patient is prescribed glucocorticoids for chronic inflammation. Which of the following is a significant side effect of long-term glucocorticoid therapy?",
      "unique_key": "Q2011652",
      "question_audio": null,
      "question_video": null,
      "map_id": 34039821,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Osteoporosis. Long-term glucocorticoid therapy is associated with bone loss and an increased risk of osteoporosis. Glucocorticoids inhibit osteoblast activity (bone-forming cells) and enhance osteoclast activity (bone-resorbing cells), leading to decreased bone density and increased fracture risk. They also reduce calcium absorption in the intestines and increase calcium excretion by the kidneys, further contributing to bone demineralization. Osteoporosis is one of the most serious and well-known complications of chronic glucocorticoid use, making option (B) the correct answer. Explanation of Incorrect Options: (A) Hypoglycemia – Incorrect. Glucocorticoids increase blood glucose levels by stimulating gluconeogenesis (glucose production in the liver) and decreasing glucose uptake in peripheral tissues. This can lead to hyperglycemia and insulin resistance, not hypoglycemia. Therefore, this option is incorrect. (C) Hypotension – Incorrect. Glucocorticoids increase blood pressure by enhancing the sensitivity of blood vessels to vasoconstrictors like norepinephrine and reducing nitric oxide production (a vasodilator). Additionally, they can cause fluid retention due to their mineralocorticoid-like effects. Therefore, they are more likely to cause hypertension rather than hypotension. (D) Hyperkalemia – Incorrect. Glucocorticoids can have mineralocorticoid effects, particularly at high doses, leading to increased sodium retention and potassium excretion. This results in hypokalemia (low potassium levels) rather than hyperkalemia.",
      "correct_choice_id": 296637,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73848,
      "choices": [
        {
          "id": 296640,
          "text": "Serum potassium levels"
        },
        {
          "id": 296641,
          "text": "Blood glucose levels"
        },
        {
          "id": 296642,
          "text": "Serum sodium levels"
        },
        {
          "id": 296643,
          "text": "Serum calcium levels"
        }
      ],
      "text": "A 30-year-old woman with primary adrenal insufficiency is treated with hydrocortisone. Which of the following monitoring parameters is most critical for this patient?",
      "unique_key": "Q7953057",
      "question_audio": null,
      "question_video": null,
      "map_id": 34659227,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Serum potassium levels. Patients with primary adrenal insufficiency (Addison’s disease) have deficient cortisol and aldosterone production. Hydrocortisone is used to replace cortisol, while fludrocortisone (a mineralocorticoid) is often needed to compensate for aldosterone deficiency. Aldosterone normally promotes renal potassium excretion, so its deficiency can lead to hyperkalemia (high potassium levels). When treating with hydrocortisone and/or fludrocortisone, monitoring serum potassium is critical to prevent severe electrolyte imbalances that could lead to arrhythmias or cardiac complications. Explanation of Incorrect Options: (B) Blood glucose levels – Incorrect. Cortisol affects glucose metabolism, and hydrocortisone can cause mild hyperglycemia. However, patients with primary adrenal insufficiency are not usually at high risk for severe hyperglycemia, making blood glucose monitoring less critical than potassium monitoring. (C) Serum sodium levels – Incorrect. Aldosterone deficiency in Addison’s disease leads to hyponatremia (low sodium levels) due to increased sodium loss in the urine. While serum sodium monitoring is important, potassium imbalances pose a more immediate and severe risk to cardiac function, making potassium monitoring more critical. (D) Serum calcium levels – Incorrect. Hydrocortisone can reduce calcium absorption and increase calcium excretion, leading to a risk of osteoporosis with long-term use. However, calcium disturbances are not an immediate or life-threatening concern in the management of adrenal insufficiency, making this a less critical monitoring parameter.",
      "correct_choice_id": 296640,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73849,
      "choices": [
        {
          "id": 296644,
          "text": "Inhibition of cortisol synthesis"
        },
        {
          "id": 296645,
          "text": "Potassium-sparing diuretic effect"
        },
        {
          "id": 296646,
          "text": "Increased sodium reabsorption"
        },
        {
          "id": 296647,
          "text": "Stimulation of aldosterone release"
        }
      ],
      "text": "A patient undergoing treatment for hyperaldosteronism is prescribed spironolactone. What is the primary pharmacological effect of this medication?",
      "unique_key": "Q6659212",
      "question_audio": null,
      "question_video": null,
      "map_id": 34016503,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Potassium-sparing diuretic effect. Spironolactone is a potassium-sparing diuretic that works by blocking aldosterone receptors in the distal tubules and collecting ducts of the kidney. Aldosterone normally promotes sodium and water retention while increasing potassium excretion. By inhibiting aldosterone, spironolactone reduces sodium reabsorption and water retention, leading to increased urine output, while simultaneously preventing potassium loss. This effect makes it particularly useful in treating hyperaldosteronism (primary aldosteronism), heart failure, and hypertension. Additionally, spironolactone has anti-androgenic properties, which can be beneficial in conditions such as polycystic ovary syndrome (PCOS) and hirsutism. Explanation of Incorrect Options: A. Inhibition of cortisol synthesis – Incorrect Spironolactone does not directly inhibit cortisol synthesis. Cortisol is regulated by the hypothalamic-pituitary-adrenal (HPA) axis, and its synthesis is primarily affected by drugs like ketoconazole or metyrapone, which inhibit enzymes in the steroidogenesis pathway. Spironolactone specifically targets aldosterone receptors, not cortisol production. C. Increased sodium reabsorption – Incorrect Spironolactone actually reduces sodium reabsorption, leading to increased sodium excretion in urine. This is the opposite of what occurs when aldosterone is active, as aldosterone promotes sodium retention. By blocking aldosterone’s effects, spironolactone reduces fluid retention and lowers blood pressure. D. Stimulation of aldosterone release – Incorrect Spironolactone does not stimulate aldosterone release; instead, it blocks aldosterone receptors, preventing its action. Aldosterone release is primarily controlled by the renin-angiotensin-aldosterone system (RAAS) and factors such as low blood pressure or high potassium levels. Spironolactone counteracts excessive aldosterone activity rather than promoting its release.",
      "correct_choice_id": 296645,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73850,
      "choices": [
        {
          "id": 296648,
          "text": "Ritodrine"
        },
        {
          "id": 296649,
          "text": "Nifedipine"
        },
        {
          "id": 296650,
          "text": "Atosiban"
        },
        {
          "id": 296651,
          "text": "Ergot alkaloids"
        }
      ],
      "text": "All are types of tocoytics except –",
      "unique_key": "Q8678518",
      "question_audio": null,
      "question_video": null,
      "map_id": 34019341,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Ergot alkaloids. Tocolytics are medications used to suppress preterm labor by relaxing the uterus (uterine smooth muscle inhibition), thereby delaying labor and allowing more time for fetal lung maturity (often with corticosteroids). Ergot alkaloids, however, are not tocolytics; instead, they are uterotonic agents that cause strong uterine contractions, making them contraindicated in preterm labor. Methylergonovine, an ergot derivative, is used to induce uterine contraction in postpartum hemorrhage (PPH) and to manage uterine atony. Since tocolytics should relax the uterus, ergot alkaloids, which promote contraction, are the incorrect option. Explanation of Incorrect Options: A. Ritodrine – Incorrect Ritodrine is a beta-2 adrenergic agonist that stimulates beta-2 receptors in the uterus, leading to smooth muscle relaxation and inhibition of uterine contractions. It was historically a common tocolytic, but due to adverse effects (such as maternal tachycardia and hyperglycemia), its use has declined in favor of safer alternatives like nifedipine and atosiban. B. Nifedipine – Incorrect Nifedipine is a calcium channel blocker (CCB) that inhibits calcium influx into uterine smooth muscle cells, reducing contractions and acting as an effective tocolytic. It is widely used due to its favorable maternal side effect profile, including lower risk of cardiovascular complications compared to beta-agonists like ritodrine. C. Atosiban – Incorrect Atosiban is an oxytocin receptor antagonist that directly inhibits oxytocin-induced uterine contractions, making it a highly effective tocolytic. It is commonly used in Europe but is not widely available in the United States. It has fewer cardiovascular side effects compared to beta-agonists and calcium channel blockers.",
      "correct_choice_id": 296651,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}